Fountainhead AM »

Neurocrine Biosciences shares owned by Fountainhead AM

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Fountainhead AM from 13F filings

Historical chart of Fountainhead AM investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Fountainhead AM consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Fountainhead AM

Quarter filed Position value Share count Share price at filing
2026-06-30 $14k 84 168.54
2020-12-31 $204k 2.1k 96.05

More positions owned by Fountainhead AM

Apple (AAPL)
Vanguard Index Fds Large Cap Etf (VV)
Amgen (AMGN)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Rus 1000 Etf (IWB)
J P Morgan Exchange Traded F Jpmorgan Intl Vl (JIVE)
Novo-nordisk A S Adr (NVO)
Microsoft Corporation (MSFT)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Eafe Value Etf (EFV)

View all positions for Fountainhead AM

Top funds holding Neurocrine Biosciences

BlackRock
Jpmorgan Chase & Co
Dodge & Cox
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
AQR Capital Management
Renaissance Technologies
Geode Capital Management
Two Sigma Investments
Vestal Point Capital
Bnp Paribas Investment Partners
Rtw Investments
Northern Trust
Morgan Stanley

View all funds holding Neurocrine Biosciences